-
Selpercatinib improves event-free survival in early-stage RET fusion-positive NSCLC
Alexander E. Drilon, MD, discusses the findings from the first randomized phase 3 trial to evaluate a RET kinase inhibitor as adjuvant therapy in RET fusion-positive lung cancer.
Recent News
-
Sleep in the ICU: Why closed eyes do not mean rest
Unconsciousness is not synonymous with sleep. Available evidence increasingly supports treating sleep as an essential component of ICU care rather than a secondary comfort measure.
-
Severe valvular dysfunction in critically ill patients
Prompt diagnosis of acute severe valvular disease and tailored medical, ventilatory, and mechanical circulatory support can help stabilize patients as a bridge to definitive valve intervention.
-
Precision immunotherapy in sepsis: Beyond one size fits all
In an era of precision immunotherapy that targets specific pathways of the immune response based on measurable biomarkers, the development of rapid, multidimensional immune phenotyping tools is essential to translate precision sepsis care from concept to bedside.
-
CHEST to unveil “Guide for Medical Directors of Respiratory Care” at CHEST 2026
Medical Directors of Respiratory Care play a critical role in overseeing respiratory services and respiratory therapy education. A new guide from the Respiratory Care Interest Group compiled practical guidance for medical directors across six key respiratory care settings.
-
When PH and ILD meet: From overlap to a unified disease paradigm
For clinicians, the shift in the PH-ILD space demands a broader perspective that integrates vascular and parenchymal disease, emphasizes early detection, and prioritizes multidisciplinary care.
-
Study demonstrates superior protection from mRNA influenza vaccine compared with standard-dose vaccines
Experts caution that further research is needed to evaluate the platform’s performance across multiple seasons and compare it with enhanced vaccines.
